IDO1 and ovarian carcinoma: Studies analyzing cancer genomics have found that high expression of IDO1 indicates poor prognosis in colorectal cancer, but in certain hormone-related cancers such as breast cancer and ovarian cancer, higher IDO1 expression is associated with significantly prolonged survival and better prognosis compared to lower IDO1 expression levels.